Talzenna
My Prescription
Payment
Select pharmacy



$20,337.00
Print or send this coupon to your phone
About Talzenna
Drug Details
Talazoparib, marketed under the name Talzenna, is a medication prescribed for certain breast and prostate cancers. It is particularly used for treating advanced or metastatic HER2-negative breast cancer in patients with specific BRCA gene mutations and metastatic, castration-resistant prostate cancer with HRR gene mutations, when combined with Xtandi (enzalutamide). Talzenna is a targeted therapy known as a PARP inhibitor. It operates by blocking the PARP protein, which normally aids cells in repairing damaged DNA. By inhibiting this protein, Talzenna disrupts the cancer cells' ability to mend their DNA, leading to their destruction and halting the growth of cancer. Patients take Talzenna orally once a day in capsule form. Some common side effects may include fatigue and reduced blood cell counts, which could necessitate blood transfusions. Always consult your healthcare provider before starting this medication to ensure it is appropriate for your specific condition.
Price history for Talzenna
30 Capsules, 0.1MG
Average retail price for Talzenna
Average SaveHealth price for Talzenna
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Talzenna dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 0.1MG | 30 Capsules | $20,337.00 | $677.90 |
| 0.25MG | 30 Capsules | $20,337.00 | $677.90 |
| 0.35MG | 30 Capsules | $20,337.00 | $677.90 |
| 0.5MG | 30 Capsules | $20,337.00 | $677.90 |
| 0.75MG | 30 Capsules | $20,337.00 | $677.90 |
| 1MG | 30 Capsules | $20,337.00 | $677.90 |
Talzenna FAQs
Talzenna is used for the treatment of certain types of breast cancer. Specifically, it is indicated for patients with deleterious or suspected deleterious germline BRCA-mutated, HER2-negative locally advanced or metastatic breast cancer. It is typically prescribed for patients who have been treated with chemotherapy in the neoadjuvant, adjuvant, or metastatic setting.
Talzenna (talazoparib) is a PARP inhibitor used in the treatment of certain types of breast cancer. Its effectiveness can vary depending on individual patient factors, such as the specific genetic mutations present and the stage of the cancer. Clinical trials have shown that Talzenna can be effective in delaying disease progression in patients with BRCA-mutated, HER2-negative locally advanced or metastatic breast cancer. However, the response to treatment can differ among patients, and it is important for individuals to discuss their specific case with their healthcare provider to understand the potential benefits and risks.
Using the SaveHealth discount card, the price of Talzenna without insurance is $20337.00.
The price of Talzenna at Walgreens is $20454.19.
The price of Talzenna at Walmart is $20454.69.